Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ReNeuron Group PLC

www.reneuron.com

Latest From ReNeuron Group PLC

Asia Deal Watch: Antibody-Drug Conjugates Reign With Alliances Involving Celltrion, Miracogen & WuXi Biologics

Celltrion and iProgen will co-develop ADC candidates, Miracogen and Synaffix sign a technology license after a successful research collaboration, and WuXi will provide clinical trial material to NBE Therapeutics.

Deals Commercial

ReNeuron's Cell Therapies Attract Fosun Pharma, A Leading Regenerative Medicines Developer

The UK cell therapy biotech ReNeuron has attracted the healthcare group, Fosun Pharma, which is building up a leading position in regenerative medicine, to develop and commercialize its products in China.

 

Deals Regenerative Medicine

ReNeuron's Cell Therapy Garners Excitement In RP-Related Vision Loss

A surprisingly strong improvement in vision has accompanied the use of proprietary stem cells in the first three retinitis pigmentosa patients in a US Phase II study, intriguing the UK biotech, ReNeuron, and maybe attracting development partners too.

 

Clinical Trials Ophthalmic

Deal Watch: BioCryst Shareholder Dissent Scuttles Planned Merger With Idera

AZ’s MedImmune to use 4D’s AAV vector technology to deliver therapies for chronic lung disease, while Roivant spinout Dermavant licenses Phase III-ready autoimmune candidate tapinarof from GSK.

Deals Commercial
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Nanotechnology, Chips, etc.
  • Pharmaceuticals
  • Therapeutic Areas
  • Cardiovascular
  • Neurology, Nervous System
  • Ophthalmic
  • Alias(es)
  • RENEURON HOLDINGS PLC
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • ReNeuron Group PLC
  • Senior Management
  • Olav Hellebø, CEO
    Michael Hunt, CFO
    John D Sinden, PhD, CSO
    Richard Beckman, MD, CMO
  • Contact Info
  • ReNeuron Group PLC
    Phone: (44) 1483 302560
    Pencoed Business Park
    Pencoed, CF35 5HY
    UK
Advertisement
Advertisement
UsernamePublicRestriction

Register